Skip Navigation


International Immunology Advance Access originally published online on June 1, 2007
International Immunology 2007 19(6):785-799; doi:10.1093/intimm/dxm047
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/6/785    most recent
dxm047v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Yates, J.
Right arrow Articles by Garden, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yates, J.
Right arrow Articles by Garden, O.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2007. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

The maintenance of human CD4+CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro

John Yates1, Flavia Rovis1, Peter Mitchell2, Behdad Afzali2, JY-S Tsang2, Marina Garin2, RI Lechler2, Giovanna Lombardi2 and OA Garden1,3

1 Regulatory T Cell Laboratory, Department of Immunology, Division of Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 ONN, UK
2 Immunoregulation Laboratory, Department of Nephrology and Transplantation, Fifth Floor, Thomas Guy House, Guy's Hospital Campus, King's College London School of Medicine at Guy's, King's College and St Thomas' Hospitals, London SE1 9RT, UK
3 Department of Veterinary Clinical Sciences, Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire AL9 7TA, UK

Correspondence to: O. A. Garden; E-mail: ogarden{at}rvc.ac.uk or o.garden{at}imperial.ac.uk

CD4+CD25+ regulatory T cells (Tregs) have far-reaching immunotherapeutic applications, the realization of which will require a greater understanding of the factors influencing their function and phenotype during ex vivo manipulation. In murine models, IL-2 plays an important role in both the maintenance of a functional Treg population in vivo and the activation of suppression in vitro. We have found that IL-2 maintains optimal function of human CD4+CD25+ Tregs in vitro and increases expression of both forkhead box protein 3, human nomenclature (FOXP3) and the distinctive markers CD25, cytotoxic T lymphocyte antigen-4 (CTLA-4) and glucocorticoid-induced tumor necrosis factor receptor superfamily member number 18 (GITR). Although IL-2 reduced spontaneous apoptosis of Tregs, this property alone could not account for the optimal maintenance of the regulatory phenotype. The inhibition of phosphatidylinositol 3-kinase (PI3K) signaling by LY294002, a chemical inhibitor of PI3K, abolished the maintenance of maximal suppressive potency by IL-2, yet had no effect on the up-regulation of FOXP3, CD25, CTLA-4 and GITR. Other common gamma chain ({gamma}c) cytokines—IL-4, IL-7 and IL-15—had similar properties, although IL-4 showed a unique lack of effect on the expression of FOXP3 or Treg markers despite maintaining maximal regulatory function. Taken together, our data suggest a model in which the {gamma}c cytokines IL-2, IL-4, IL-7 and IL-15 maintain the optimal regulatory function of human CD4+CD25+ T cells in a PI3K-dependent manner, offering new insight into the effective manipulation of Tregs ex vivo.

Keywords: common gamma chain, FOXP3, LY294002, phosphatidylinositol 3-kinase


Transmitting editor: A. Cooke

Received 13 July 2006, accepted 23 March 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
N. R. Locke, S. J. Patterson, M. J. Hamilton, L. M. Sly, G. Krystal, and M. K. Levings
SHIP Regulates the Reciprocal Development of T Regulatory and Th17 Cells
J. Immunol., July 15, 2009; 183(2): 975 - 983.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. B. Ahmed, N. Belhadj Hmida, N. Moes, S. Buyse, M. Abdeladhim, H. Louzir, and N. Cerf-Bensussan
IL-15 Renders Conventional Lymphocytes Resistant to Suppressive Functions of Regulatory T Cells through Activation of the Phosphatidylinositol 3-Kinase Pathway
J. Immunol., June 1, 2009; 182(11): 6763 - 6770.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. M. Collazo, D. Wood, K. H. T. Paraiso, E. Lund, R. W. Engelman, C.-T. Le, D. Stauch, K. Kotsch, and W. G. Kerr
SHIP limits immunoregulatory capacity in the T-cell compartment
Blood, March 26, 2009; 113(13): 2934 - 2944.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. Y. Wuest, J. Willette-Brown, S. K. Durum, and A. A. Hurwitz
The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells
J. Leukoc. Biol., October 1, 2008; 84(4): 973 - 980.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.